We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000786:SZSEBeijing New Building Materials Public Limited Company Analysis

Data as of 2026-05-22 - not real-time

CN¥23.78

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Beijing New Building Materials is trading at CNY 23.78, well below its 20‑day (CNY 25.45), 50‑day (CNY 25.70) and 200‑day (CNY 25.74) simple moving averages, signalling a bearish technical backdrop. The RSI sits at 33, hinting at oversold conditions, while the MACD remains in a bearish configuration. Despite the price weakness, the stock’s trailing PE of 14 is roughly half the industry average of 29, and it offers a solid 3.62% dividend yield with a 51% payout ratio, suggesting attractive income potential. However, the DCF‑derived fair value of CNY 14.7 is far below the current market price, implying the market may be overpaying relative to intrinsic estimates. Volatility is elevated at 25% over the past 30 days, yet beta is very low (≈0.11), indicating limited systematic risk. The share sits near its technical support at CNY 23.63, with resistance around CNY 27.06, and the upside/downside metric points to a potential 35% upside relative to the current level.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below all major moving averages indicating bearish momentum
  • RSI near oversold levels offering limited near‑term upside
  • Proximity to technical support at CNY 23.63

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • PE roughly half of industry average, suggesting valuation headroom
  • Strong dividend yield (3.62%) with sustainable payout
  • Low systematic risk (beta ≈0.11) and stable trading volume

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent cash generation and net cash position
  • Defensive exposure to building‑materials demand in China
  • Attractive dividend income supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth-1.30%
Profit Margin11.38%
P/E Ratio14.1
ROE10.43%
ROA5.45%
Debt/Equity2.76
P/B Ratio1.4
Op. Cash FlowCN¥3.8B
Free Cash FlowCN¥1.7B
Industry P/E29.5

Technical Analysis

TrendBearish
RSI33.0
SupportCN¥23.63
ResistanceCN¥27.06
MA 20CN¥25.45
MA 50CN¥25.70
MA 200CN¥25.74
MACDBearish
VolumeStable
Fear & Greed Index91.52

Valuation

Fair ValueCN¥14.70
Target PriceCN¥32.14
Upside/Downside35.15%
GradeOvervalued
TypeValue
Dividend Yield3.62%

Risk Assessment

Beta0.11
Volatility25.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.